Acquired in-process research and development expenses
Breakdown
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|
| Pharmaceuticals | $19.8M | $2.2M | $54.5M | $56.5M |
| Total | — | — | — | — |
Segments
PharmaceuticalsView metric
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|
| Pharmaceuticals | $19.8M | $2.2M | $54.5M | $56.5M |
| Total | — | — | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.